Stay updated with breaking news from Righteous Crane. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SINGAPORE- Japan's Mitsui & Co, said on Thursday (April 4) it had teamed up with Rohto Pharmaceutical Co to buy Eu Yan Sang International in a deal valuing the Singapore-based traditional Chinese medicines firm at S$800 million. Mitsui said in a statement that a special purpose company jointly owned by Mitsui and Rohto would acquire around 86 per cent of...
Japan's Mitsui & Co said on Thursday it had teamed up with Rohto Pharmaceutical Co to buy Eu Yan Sang International.
Japan's Mitsui & Co said on Thursday it had teamed up with Rohto Pharmaceutical Co to buy Eu Yan Sang International in a deal valuing the Singapore-based traditional Chinese medicines firm at S$800 million ($594 million). Mitsui said in a statement that a special purpose company jointly owned by Mitsui and Rohto would acquire around 86% of Eu Yan Sang from Righteous Crane Holding. Righteous Crane Holding is owned by a fund managed by Tower Capital Asia, a unit of Temasek Holdings and founding fa
Japan's Mitsui & Co said on Thursday it had teamed up with Rohto Pharmaceutical Co to buy Eu Yan Sang International in a deal valuing the Singapore-based traditional Chinese medicines firm at S$800...
A special purpose entity will buy around 86 per cent of the TCM maker from Righteous Crane Holding. Read more at straitstimes.com.